Galectin Therapeutics Inc.

8-K Unregistered sale of equity Aug 4, 2026 8-K Regulation FD disclosure Jun 23, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Director or officer change Mar 17, 2026 8-K Director or officer change Jan 21, 2026 8-K Director or officer change Jan 12, 2026 8-K Entered a material agreement Dec 19, 2025 8-K Shareholder vote results Dec 8, 2025 8-K Regulation FD disclosure Dec 3, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Regulation FD disclosure Nov 10, 2025 8-K Regulation FD disclosure Sep 8, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Director or officer change Jul 9, 2025 8-K Regulation FD disclosure Jun 16, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Regulation FD disclosure; Other events May 12, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Mar 5, 2025 8-K Other events Feb 18, 2025 8-K Shareholder vote results Jan 28, 2025 8-K Regulation FD disclosure Jan 23, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Other events Dec 20, 2024 8-K Regulation FD disclosure Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure Sep 9, 2024 8-K Results of operations (earnings release) Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change Aug 1, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024